Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALA photodynamic therapy for premalignant vulvar disorders
2011-003134-13Phase 2Active
- Sponsor
- Erasmus MC
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of 5-aminolevulinic acid in vulvar intraepithelial neoplasia (VIN) and Kraurosis vulvae (2 arms), sponsored by Erasmus MC. Primary endpoints: Clinical response by lesion size reduction, Histological regression and 1 more. Started Nov 2011; status: active.
02
Drugs
5-aminolevulinic acid
03
Conditions
vulvar intraepithelial neoplasia (VIN)Kraurosis vulvae
Beyond the preview
Go deeper on 2011-003134-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003134-13.